Webster Equity’s Bristol Hospice preps sale process

The upcoming process for Bristol comes as Webster runs a secondaries process for two existing Fund III portfolio companies: BayMark and Pharmalogic.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this